20Slash20 Inc., the creator of The Eye Drink, announced its participation in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for Sept. 9–10, 2026, at The Westin New York Grand Central. CEO Dr. Roger Wu will deliver an investor presentation at 9:35 a.m. ET on Sept. 9, followed by one-on-one meetings with investors. The conference aims to bring together growth companies, investors, and industry professionals across life sciences and other emerging sectors.
The company's flagship product, The Eye Drink, is positioned as the world’s first ready-to-drink functional beverage formulated with science-backed ingredients to support eye health. It targets individuals who spend extended hours daily on cellphones or computers, addressing screen-induced eye problems. The beverage is designed to be a convenient and tasty solution for maintaining eye health in today’s screen-centric world.
The significance of this presentation lies in the growing awareness of digital eye strain and the increasing demand for functional beverages that offer health benefits beyond basic nutrition. According to the Vision Council, nearly 80% of American adults report using digital devices for more than two hours daily, with many experiencing symptoms of digital eye strain, such as dry eyes, blurred vision, and headaches. 20Slash20 aims to capitalize on this market need by offering a product that combines convenience with targeted health benefits.
The company's participation in the conference provides a platform to attract potential investors and partners, as the functional beverage market continues to expand. The global functional beverages market was valued at over $125 billion in 2025 and is projected to grow at a compound annual growth rate of 7% from 2026 to 2030, according to industry reports. This growth is driven by increasing consumer focus on health and wellness, particularly among millennials and Gen Z, who are heavy users of digital devices.
20Slash20’s approach aligns with this trend, offering a product that not only addresses a specific health concern but also fits into busy lifestyles. The company’s emphasis on science-backed ingredients could differentiate it in a crowded market, where many beverages make broad health claims without substantial evidence.
For more information about the conference or the company, interested parties can visit the official press release at https://ibn.fm/tm2lT. Additional details about 20Slash20 can be found on its website, and information about InvestorWire, which syndicated this announcement, is available at https://www.InvestorWire.com. The company is headquartered in Austin, Texas, and can be reached by phone at 512.354.7000.
